Enhanced lovastatin production by solid state fermentation ofMonascus ruber

被引:0
作者
Bao-Jun Xu
Qi-Jun Wang
Xiao-Qin Jia
Chang-Keun Sung
机构
[1] College of Agriculture and Biotechnology Chungnam National University,Department of Food Science and Technology
[2] Dalian University,The pharmaceutical Institute
[3] South China University of Technology,College of Food and Bioengineering
来源
Biotechnology and Bioprocess Engineering | 2005年 / 10卷
关键词
lovastatin; solid state fermentation;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to optimize the solid state cultivation ofMonascus ruber on sterile rice. A single-level-multiple-factor and a single-factor-multiple-level experimental design were employed to determine the optimal medium constituents and to optimize carbon and nitrogen source concentrations for lovastatin production. Simultaneous quantitative analyses of the β-hydroxyacid form and β-hydroxylactone for of lovastatin were performed by the high performance liquid chromatography (HPLC) method with a UV photodiode-array (PDA) detector. The total lovastatin yield (4≈6 mg/g, average of five repeats) was achieved by adding soybean powder, glycerol, sodium nitrate, and acetic acid at optimal composition of the medium increased by almost 2 times the yield observed prior to optimization. The experimental results also indicated that the β-hydroxylactone form of lovastatin (LFL) and the β-hydroxyacid form of lovastatin (AFL) simultaneously existed in solid state cultures ofMonascus ruber, while the latter was the dominant form in the middle-late stage of continued fermentation. These results indicate that optimized culture conditions can be used for industrial production of lovastatin to obtain high yields.
引用
收藏
页码:78 / 84
页数:6
相关论文
共 85 条
[1]  
Alberts A. W.(1980)Mevinolin: A highly potent competitive inhibitor of hydroxymethyl-glutaryl-coenzyme A reductase and a cholesterol-lowering agent Proc. Natl. Acad. Sci. USA. 77 3957-3961
[2]  
Chen J.(1976)ML-236 A, ML-236 B and ML-236 C, a new inhibitors of cholesterogenesis produced by J. Antibiot. 29 1346-1349
[3]  
Kuron G.(1979)Monacolin K. a new hypocholesterolemic agent produced by a J. Antibiot. 32 852-854
[4]  
Hunt V.(1992) sp. Bioprocess Eng. 8 1-7
[5]  
Hoffman C.(1993)Interaction of cell morphology and transport process in the lovastatin fermentation FEMS Microbiol. Lett. 113 333-338
[6]  
Endo A.(2000)Pleurotus fungi produce mevinolin, an inhibitor of HMG CoA reductase Process. Biochem. 36 363-368
[7]  
Kuroda M.(2001)Repeated fed-batch process for improving lovastatin production J. Chin. Inst. Chem. Eng. 2 135-142
[8]  
Tsujita Y.(2003)Influence of increased dissolved oxygen tensions by agitation on the secondary metabolite production by a mutant of Enzyme Microb. Technol. 33 270-277
[9]  
Endo A.(2003) in a 5-L fermentor Process Biochen. 38 1317-1326
[10]  
Gbewonyo K.(2002)Production of lovastatin by Enzyme Microb. Technol. 30 889-894